Clinical Trial Update: Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for Palonosetron in preventing chemotherapy-induced nausea and vomiting have been completed, reporting safety and efficacy findin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Conditions: Nausea, Vomiting | Phase 2 | Status: COMPLETED